uniQure N.V. SEC filings QURE
uniQure N.V. has 953 filings in SEC EDGAR's recent list, going back to Nov 8, 2013. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| CT ORDER | Filing | Jun 29, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 5, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 6, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2019 | — |
| CORRESP | Letter to the SEC | Nov 22, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2019 | — |
| CT ORDER | Filing | Apr 11, 2019 | — |
| CT ORDER | Filing | Feb 21, 2019 | — |
| CT ORDER | Filing | Dec 4, 2017 | — |
| CT ORDER | Filing | Oct 3, 2017 | — |
| EFFECT | Filing | May 26, 2017 | — |
| CORRESP | Letter to the SEC | May 23, 2017 | — |
| CORRESP | Letter to the SEC | May 15, 2017 | — |
| EFFECT | Filing | Mar 30, 2017 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2017 | — |
| AW | Filing | Mar 28, 2017 | — |
| AW | Filing | Mar 27, 2017 | — |
| CT ORDER | Filing | Feb 21, 2017 | — |
| CT ORDER | Filing | Aug 25, 2015 | — |
| EFFECT | Filing | Mar 13, 2015 | — |
| CT ORDER | Filing | Feb 5, 2014 | — |
| EFFECT | Filing | Feb 4, 2014 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2014 | — |
| CORRESP | Letter to the SEC | Feb 3, 2014 | — |
| CERTNAS | Auto-generated paper document | Jan 31, 2014 | — |
| CORRESP | Letter to the SEC | Jan 31, 2014 | — |
| CORRESP | Letter to the SEC | Jan 31, 2014 | — |
| 8-A12B | Filing | Jan 31, 2014 | — |
| CORRESP | Letter to the SEC | Jan 17, 2014 | — |
| CORRESP | Letter to the SEC | Jan 17, 2014 | — |
| UPLOAD | Letter from the SEC | Jan 13, 2014 | — |
| DRS/A | Filing | Dec 19, 2013 | — |
| DRSLTR | Filing | Dec 18, 2013 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2013 | — |
| DRS | Filing | Nov 8, 2013 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QURE (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Amsterdam
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1590560
- Former names
- uniQure B.V. (until Feb 6, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.